✦ LIBER ✦

P394 Rate of and response to dose escalation in patients treated with adalimumab for moderately to severely active ulcerative colitis: subanalysis of ULTRA 2

✍ Scribed by Wolf, D.; D'Haens, G.; Sandborn, W.; Colombel, J.-F.; Van Assche, G.; Lazar, A.; Zhou, Q.; Robinson, A.; Chao, J.; Thakkar, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Escalation to weekly dosing recaptures r

✍ Wolf, D.; D'Haens, G.; Sandborn, W. J.; Colombel, J.-F.; Van Assche, G.; Robinso 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB

P207 One-year response and remission rat

✍ W. Sandborn; G. D'Haens; J.-F. Colombel; G. Van Assche; D. Wolf; M. Kron; A. Laz 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 52 KB

Efficacy and safety of adalimumab in Jap

✍ Suzuki, Yasuo; Motoya, Satoshi; Hanai, Hiroyuki; Matsumoto, Takayuki; Hibi, Tosh 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 345 KB

Su2083 One-Year Response and Remission R

✍ Sandborn, William J.; D'Haens, Geert R.; Colombel, Jean-Frederic; Van Assche, Ge 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Four-Year Maintenance Treatment With Ada

✍ Colombel, Jean-Frederic; Sandborn, William J; Ghosh, Subrata; Wolf, Douglas C; P 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 312 KB

Sa1203 Pharmacokinetics and Exposure-Res

✍ Adedokun, Omoniyi J.; Xu, Zhenhua; Marano, Colleen W; Strauss, Richard; Zhang, H 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 319 KB